Thus, hypoketonemic hypoglycemia induced by insulin injection or insulin secretagogue administration may be associated with a higher risk of cardiovascular events when compared with hyperketonemic hypoglycemia induced by starvation or SGLT2 inhibitor therapy. Here, SLC5A2 is linked to Hypoglycemia.